These four Canadian medical marijuana stocks are buys, says PI


August 16, 2016 Facebook Twitter LinkedIn Google+ News


With multiple near-term catalysts on the horizon, PI Financial thinks investors should be positioned in quality licensed medical marijuana producers.

Yesterday, PI analyst Jason Zandberg initiated coverage of four stocks in the space, Aphria (TSXV:APH), Canopy Growth Corp. (TSXV:CGC), Mettrum Health (TSXV:MT) and OrganiGram Holdings (TSXV:OGI) with “Buy” ratings. The analyst rates the risk profile of these stocks as “Speculative”.

Zandberg notes that despite an environment that is rapidly becoming more favourable to licensed producers, to date only about five-thousand doctors have recommended marijuana to their patients, a figure that represents just 7 per cent of all practicing doctors in the country. The analyst points out that under MMPR regulations, there have been just 34 licenses awarded to grow and/or sell marijuana and 22 licenses to sell cannabis oil.

Read More

Comments
  1. Linda Harper said on August 24, 2016 11:45 am:

    I’d like to find out how to invest in the the Aphria and Canopy Growth Corp stocks.

  2. tony said on October 1, 2016 6:40 pm:

    go to the bank, open an investors account, view the tutorial videos in the investors account, buy low , sell high

  3. Joe Ahoodnick said on December 15, 2016 1:31 pm:

    Go to a financial advisor at any TD bank and tell them you want to purchase shares in Marijuana companies. Also ask them to set you up with online trading so that you can do it yourself